Association of renin-angiotensin-aldosterone system inhibitors with best COVID-19 outcomes in a diabetic population of the Veneto Region (north-east Italy): a lesson for endemic phase?
MD Francesco Piarulli, MD Eugenio Ragazzi, MD Massimo Carollo, MSc Luca Benacchio, Fabio Piovanello, MD Ivana Simoncello, MD Annunziata Lapolla
Nutrition, Metabolism and Cardiovascular Diseases, doi:10.1016/j.numecd.2023.06.016
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
J o u r n a l P r e -p r o o f
References
Al-Hashem, Al-Humayed, Amin, Metformin inhibits mTOR-HIF-1α axis and profibrogenic and inflammatory biomarkers in thioacetamide-induced hepatic tissue alterations, J Cell Physiol,
doi:10.1002/jcp.27616Apicella, Campopiano, Mantuano, Mazoni, Coppelli et al., COVID-19 in people with diabetes: understanding the reasons for worse outcomes, Lancet Diabetes Endocrinol
Barron, Bakhai, Kar, Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study, Lancet Diabetes Endocrinol,
doi:10.1016/S2213-8587(20)30272-2Chao, Tseng, Wu, Shih, Yi et al., Higher glycemic variability within the first day of ICU admission is associated with increased 30-day mortality in ICU patients with sepsis, Ann Intensive Care,
doi:10.1186/s13613-020-0635-3Chen, Wu, Wang, Yu, Sun, The Impact of COVID-19 on Blood Glucose: A Systematic Review and Meta-Analysis, Front Endocrinol (Lausanne),
doi:10.3389/fendo.2020.574541Deng, Peng, Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China, J Clin Med,
doi:10.3390/jcm9020575Deng, Peng, Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China, J Clin Med,
doi:10.3390/jcm9020575Fadini, Morieri, Longato, Avogaro, Prevalence and impact of diabetes among people infected with SARS-CoV-2, J Endocrinol Invest,
doi:10.1007/s40618-020-01236-2Fang, Karakiulakis, Roth, Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?, Lancet Respir Med,
doi:10.1016/S2213-2600Guo, Zhu, Hong, Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis, Hypertension,
doi:10.1161/HYPERTENSIONAHA.120.15572Han, Ma, Sun, Association Between Anti-diabetic Agents and Clinical Outcomes of COVID-19 in Patients with Diabetes: A Systematic Review and Meta-Analysis, Arch Med Res,
doi:10.1016/j.arcmed.2021.08.002Hickey, Grant, Dunning, Siepe, Statistical primer: sample size and power calculations-why, when and how?, Eur J Cardiothorac Surg,
doi:10.1093/ejcts/ezy169Hm, Gareeb, Alblihed, Cruz-Martins, Batiha, COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin, Front Med (Lausanne),
doi:10.3389/fmed.2021.644295Hm, Gareeb, Alblihed, Guerreiro, Cruz-Martins et al., COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus, Front Cardiovasc Med,
doi:10.3389/fcvm.2021.644095Holman, Knighton, Kar, Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study, Lancet Diabetes Endocrinol,
doi:10.1016/S2213-8587(20)30271-0Iacobellis, Penaherrera, Bermudez, Mizrachi, Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes, Diabetes Res Clin Pract,
doi:10.1016/j.diabres.2020.108185Li, Wang, Chen, Zhang, Deng, Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China, JAMA Cardiol,
doi:10.1001/jamacardio.2020.1624Lippi, Favaloro, D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis, Thromb Haemost,
doi:10.1055/s-0040-Loader, Taylor, Lampa, Sundström, Renin-Angiotensin Aldosterone System Inhibitors and COVID-19: A Systematic Review and Meta-Analysis Revealing Critical Bias Across a Body of Observational Research,
doi:10.1161/JAHA.122.025289Longato, Camillo, Sparacino, Saccavini, Avogaro et al., Diabetes diagnosis from administrative claims and estimation of the true prevalence of diabetes among 4.2 million individuals of the Veneto region, Nutr Metab Cardiovasc Dis,
doi:10.1016/j.numecd.2019.08.017Luk, Yip, Zhang, Glucose-lowering drugs and outcome from COVID-19 among patients with type 2 diabetes mellitus: a population-wide analysis in Hong Kong, BMJ Open,
doi:10.1136/bmjopen-2021-052310Mancia, Rea, Ludergnani, Apolone, Corrao, Renin-Angiotensin-Aldosterone System Blockers and the Riskof Covid-19, N Engl J Med,
doi:10.1056/NEJMoa2006923Mirani, Favacchio, Carrone, Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospitalin Lombardy, Italy. Diabetes Care,
doi:10.2337/dc20-1340Nyland, Raja-Khan, Bettermann, Diabetes, Drug Treatment, and Mortality in COVID-19: A Multinational Retrospective Cohort Study, Diabetes,
doi:10.2337/db21-0385Petrilli, Jones, Yang, Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease, BMJ,
doi:10.1136/bmj.m1966Piarulli, Sartore, Sechi, Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects, Oxid Med Cell Longev,
doi:10.1155/2017/9185272Rameshrad, Razavi, Ferns, Hosseinzadeh, Pharmacology of dipeptidyl peptidase-4 inhibitors and its use in the management of metabolic syndrome: a comprehensive review on drug repositioning, Daru,
doi:10.1007/s40199-019-00238-7Rawshani, Kjölhede, Rawshani, Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: A nationwide retrospective cohort study, Lancet Reg Health Eur,
doi:10.1016/j.lanepe.2021.100105Rayman, Lumb, Kennon, Guidance on the management of Diabetic Ketoacidosis in the exceptional circumstances of the COVID-19 pandemic, Diabet Med,
doi:10.1111/dme.14328Reynolds, Adhikari, Pulgarin, Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19, N Engl J Med,
doi:10.1056/NEJMoa2008975Richardson, Hirsch, Narasimhan, Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area [published correction appears in JAMA, JAMA,
doi:10.1001/jama.2020.6775Scheen, Marre, Thivolet, Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports, Diabetes Metab,
doi:10.1016/j.diabet.2020.05.008Singh, Rathore, Khan, Mortality and Severity in COVID-19 Patients on ACEIs and ARBs-A Systematic Review, Meta-Analysis, and Meta-Regression Analysis, Front Med (Lausanne),
doi:10.3389/fmed.2021.703661Singh, Singh, Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19, Diabetes Res Clin Pract,
doi:10.1016/j.diabres.2020.108382Solerte, 'addio, Trevisan, Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study, Diabetes Care,
doi:10.2337/dc20-1521Superiore, Sanità, Iss), Characteristics of SARS-CoV-2 patients dying in Italy
Toniolo, Mantoan, Maresso, Veneto Region, Italy. Health system review, Health Syst Transit
Vaduganathan, Vardeny, Michel, Mcmurray, Pfeffer et al., Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19, N Engl J Med,
doi:10.1056/NEJMsr2005760Valencia, Peiró, Lorenzo, Sánchez-Ferrer, Eckel et al., DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?, Front Pharmacol,
doi:10.3389/fphar.2020.01161Vankadari, Wilce, Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26, Emerg Microbes Infect,
doi:10.1080/22221751.2020.1739565Wargny, Potier, Gourdy, Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study, Diabetologia,
doi:10.1007/s00125-020-05351-wZhang, Dong, Cao, Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China, Allergy,
doi:10.1111/all.14238Zhang, Zhu, Cai, Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 [published correction appears in Circ Res, Circ Res,
doi:10.1161/CIRCRESAHA.120.317134Zhou, Chi, Lv, Wang, Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19), Diabetes Metab Res Rev,
doi:10.1002/dmrr.3377{ 'indexed': {'date-parts': [[2023, 6, 26]], 'date-time': '2023-06-26T04:34:56Z', 'timestamp': 1687754096806},
'reference-count': 0,
'publisher': 'Elsevier BV',
'license': [ { 'start': { 'date-parts': [[2023, 6, 1]],
'date-time': '2023-06-01T00:00:00Z',
'timestamp': 1685577600000},
'content-version': 'tdm',
'delay-in-days': 0,
'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}],
'content-domain': { 'domain': [ 'clinicalkey.fr', 'clinicalkey.jp', 'clinicalkey.es', 'clinicalkey.com.au',
'clinicalkey.com', 'nmcd-journal.com', 'elsevier.com',
'sciencedirect.com'],
'crossmark-restriction': True},
'published-print': {'date-parts': [[2023, 6]]},
'DOI': '10.1016/j.numecd.2023.06.016',
'type': 'journal-article',
'created': {'date-parts': [[2023, 6, 25]], 'date-time': '2023-06-25T08:20:12Z', 'timestamp': 1687681212000},
'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy',
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'Association of renin-angiotensin-aldosterone system inhibitors with best COVID-19 outcomes in a '
'diabetic population of the Veneto Region (north-east Italy): a lesson for endemic phase?',
'prefix': '10.1016',
'author': [ { 'ORCID': 'http://orcid.org/0000-0002-1193-4410',
'authenticated-orcid': False,
'given': 'Francesco',
'family': 'Piarulli',
'sequence': 'first',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0002-0390-6823',
'authenticated-orcid': False,
'given': 'Eugenio',
'family': 'Ragazzi',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0002-6523-6036',
'authenticated-orcid': False,
'given': 'Massimo',
'family': 'Carollo',
'sequence': 'additional',
'affiliation': []},
{'given': 'Luca', 'family': 'Benacchio', 'sequence': 'additional', 'affiliation': []},
{'given': 'Fabio', 'family': 'Piovanello', 'sequence': 'additional', 'affiliation': []},
{'given': 'Ivana', 'family': 'Simoncello', 'sequence': 'additional', 'affiliation': []},
{'given': 'Annunziata', 'family': 'Lapolla', 'sequence': 'additional', 'affiliation': []}],
'member': '78',
'container-title': 'Nutrition, Metabolism and Cardiovascular Diseases',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0939475323002491?httpAccept=text/xml',
'content-type': 'text/xml',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://api.elsevier.com/content/article/PII:S0939475323002491?httpAccept=text/plain',
'content-type': 'text/plain',
'content-version': 'vor',
'intended-application': 'text-mining'}],
'deposited': { 'date-parts': [[2023, 6, 25]],
'date-time': '2023-06-25T08:20:12Z',
'timestamp': 1687681212000},
'score': 1,
'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0939475323002491'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2023, 6]]},
'references-count': 0,
'alternative-id': ['S0939475323002491'],
'URL': 'http://dx.doi.org/10.1016/j.numecd.2023.06.016',
'relation': {},
'ISSN': ['0939-4753'],
'subject': [ 'Cardiology and Cardiovascular Medicine', 'Nutrition and Dietetics',
'Endocrinology, Diabetes and Metabolism', 'Medicine (miscellaneous)'],
'container-title-short': 'Nutrition, Metabolism and Cardiovascular Diseases',
'published': {'date-parts': [[2023, 6]]},
'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'},
{ 'value': 'Association of renin-angiotensin-aldosterone system inhibitors with best '
'COVID-19 outcomes in a diabetic population of the Veneto Region (north-east '
'Italy): a lesson for endemic phase?',
'name': 'articletitle',
'label': 'Article Title'},
{ 'value': 'Nutrition, Metabolism and Cardiovascular Diseases',
'name': 'journaltitle',
'label': 'Journal Title'},
{ 'value': 'https://doi.org/10.1016/j.numecd.2023.06.016',
'name': 'articlelink',
'label': 'CrossRef DOI link to publisher maintained version'},
{'value': 'article', 'name': 'content_type', 'label': 'Content Type'},
{ 'value': '© 2023 The Italian Diabetes Society, the Italian Society for the Study of '
'Atherosclerosis, the Italian Society of Human Nutrition and the Department of '
'Clinical Medicine and Surgery, Federico II University. Published by Elsevier '
'B.V. All rights reserved.',
'name': 'copyright',
'label': 'Copyright'}]}
